vs
Nutex Health, Inc.（NUTX）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
LiveRamp Holdings, Inc.的季度营收约是Nutex Health, Inc.的1.4倍（$212.2M vs $151.7M），LiveRamp Holdings, Inc.净利率更高（18.8% vs 7.8%，领先11.0%），LiveRamp Holdings, Inc.同比增速更快（8.6% vs -41.1%），过去两年Nutex Health, Inc.的营收复合增速更高（50.0% vs 11.1%）
Nutex Health是一家总部位于美国得克萨斯州休斯敦的营利性医疗企业，核心业务为运营各类医疗机构，是美国本土医疗领域的专业运营机构，致力于为当地市场提供相关医疗服务与场地运营支持。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
NUTX vs RAMP — 直观对比
营收规模更大
RAMP
是对方的1.4倍
$151.7M
营收增速更快
RAMP
高出49.7%
-41.1%
净利率更高
RAMP
高出11.0%
7.8%
两年增速更快
NUTX
近两年复合增速
11.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $151.7M | $212.2M |
| 净利润 | $11.8M | $39.9M |
| 毛利率 | 30.4% | 71.9% |
| 营业利润率 | 20.4% | 18.6% |
| 净利率 | 7.8% | 18.8% |
| 营收同比 | -41.1% | 8.6% |
| 净利润同比 | -80.8% | 255.7% |
| 每股收益（稀释后） | $2.34 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NUTXRAMP
| Q4 25 | $151.7M | $212.2M | ||
| Q3 25 | $267.8M | $199.8M | ||
| Q2 25 | $244.0M | $194.8M | ||
| Q1 25 | $211.8M | $188.7M | ||
| Q4 24 | $257.6M | $195.4M | ||
| Q3 24 | $78.8M | $185.5M | ||
| Q2 24 | $76.1M | $176.0M | ||
| Q1 24 | $67.5M | $171.9M |
净利润NUTXRAMP
| Q4 25 | $11.8M | $39.9M | ||
| Q3 25 | $55.4M | $27.4M | ||
| Q2 25 | $-17.7M | $7.7M | ||
| Q1 25 | $21.2M | $-6.3M | ||
| Q4 24 | $61.6M | $11.2M | ||
| Q3 24 | $-8.8M | $1.7M | ||
| Q2 24 | $-364.0K | $-7.5M | ||
| Q1 24 | $-364.0K | $-5.4M |
毛利率NUTXRAMP
| Q4 25 | 30.4% | 71.9% | ||
| Q3 25 | 57.8% | 70.2% | ||
| Q2 25 | 51.2% | 70.1% | ||
| Q1 25 | 55.9% | 69.3% | ||
| Q4 24 | 55.0% | 71.9% | ||
| Q3 24 | 27.8% | 72.4% | ||
| Q2 24 | 29.7% | 70.6% | ||
| Q1 24 | 15.1% | 72.2% |
营业利润率NUTXRAMP
| Q4 25 | 20.4% | 18.6% | ||
| Q3 25 | 48.7% | 10.7% | ||
| Q2 25 | 13.8% | 3.7% | ||
| Q1 25 | 38.1% | -6.1% | ||
| Q4 24 | 44.4% | 7.5% | ||
| Q3 24 | 12.3% | 4.0% | ||
| Q2 24 | 7.0% | -3.0% | ||
| Q1 24 | 2.1% | -8.3% |
净利率NUTXRAMP
| Q4 25 | 7.8% | 18.8% | ||
| Q3 25 | 20.7% | 13.7% | ||
| Q2 25 | -7.3% | 4.0% | ||
| Q1 25 | 10.0% | -3.3% | ||
| Q4 24 | 23.9% | 5.7% | ||
| Q3 24 | -11.2% | 0.9% | ||
| Q2 24 | -0.5% | -4.3% | ||
| Q1 24 | -0.5% | -3.1% |
每股收益（稀释后）NUTXRAMP
| Q4 25 | $2.34 | $0.62 | ||
| Q3 25 | $7.76 | $0.42 | ||
| Q2 25 | $-2.95 | $0.12 | ||
| Q1 25 | $3.33 | $-0.10 | ||
| Q4 24 | $11.56 | $0.17 | ||
| Q3 24 | $-1.72 | $0.03 | ||
| Q2 24 | $-0.07 | $-0.11 | ||
| Q1 24 | $-0.08 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $185.6M | $403.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $329.4M | $962.3M |
| 总资产 | $918.5M | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NUTXRAMP
| Q4 25 | $185.6M | $403.4M | ||
| Q3 25 | $166.0M | $376.9M | ||
| Q2 25 | $96.7M | $371.1M | ||
| Q1 25 | $84.7M | $420.8M | ||
| Q4 24 | $40.6M | $384.3M | ||
| Q3 24 | $46.9M | $348.4M | ||
| Q2 24 | $40.8M | $342.7M | ||
| Q1 24 | $30.0M | $368.9M |
股东权益NUTXRAMP
| Q4 25 | $329.4M | $962.3M | ||
| Q3 25 | $317.2M | $943.8M | ||
| Q2 25 | $235.3M | $947.8M | ||
| Q1 25 | $176.9M | $948.9M | ||
| Q4 24 | $132.4M | $957.7M | ||
| Q3 24 | $60.4M | $932.1M | ||
| Q2 24 | $62.7M | $951.9M | ||
| Q1 24 | $63.0M | $949.1M |
总资产NUTXRAMP
| Q4 25 | $918.5M | $1.3B | ||
| Q3 25 | $964.5M | $1.2B | ||
| Q2 25 | $841.0M | $1.2B | ||
| Q1 25 | $761.9M | $1.3B | ||
| Q4 24 | $655.3M | $1.3B | ||
| Q3 24 | $438.5M | $1.2B | ||
| Q2 24 | $422.4M | $1.2B | ||
| Q1 24 | $404.3M | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $70.4M | — |
| 自由现金流经营现金流 - 资本支出 | $69.0M | — |
| 自由现金流率自由现金流/营收 | 45.5% | — |
| 资本支出强度资本支出/营收 | 0.9% | 0.1% |
| 现金转化率经营现金流/净利润 | 5.95× | — |
| 过去12个月自由现金流最近4个季度 | $245.6M | — |
8季度趋势，按日历期对齐
经营现金流NUTXRAMP
| Q4 25 | $70.4M | — | ||
| Q3 25 | $99.5M | $57.4M | ||
| Q2 25 | $27.3M | $-15.8M | ||
| Q1 25 | $51.0M | — | ||
| Q4 24 | $54.0K | $45.1M | ||
| Q3 24 | $6.8M | $55.6M | ||
| Q2 24 | $13.3M | $-9.3M | ||
| Q1 24 | $3.1M | — |
自由现金流NUTXRAMP
| Q4 25 | $69.0M | — | ||
| Q3 25 | $99.2M | $56.8M | ||
| Q2 25 | $26.5M | $-16.2M | ||
| Q1 25 | $50.9M | — | ||
| Q4 24 | $-341.0K | $44.8M | ||
| Q3 24 | $6.2M | $55.4M | ||
| Q2 24 | $12.7M | $-9.6M | ||
| Q1 24 | $2.3M | — |
自由现金流率NUTXRAMP
| Q4 25 | 45.5% | — | ||
| Q3 25 | 37.0% | 28.4% | ||
| Q2 25 | 10.9% | -8.3% | ||
| Q1 25 | 24.0% | — | ||
| Q4 24 | -0.1% | 22.9% | ||
| Q3 24 | 7.8% | 29.8% | ||
| Q2 24 | 16.7% | -5.4% | ||
| Q1 24 | 3.4% | — |
资本支出强度NUTXRAMP
| Q4 25 | 0.9% | 0.1% | ||
| Q3 25 | 0.1% | 0.3% | ||
| Q2 25 | 0.3% | 0.2% | ||
| Q1 25 | 0.0% | 0.2% | ||
| Q4 24 | 0.2% | 0.1% | ||
| Q3 24 | 0.8% | 0.1% | ||
| Q2 24 | 0.7% | 0.1% | ||
| Q1 24 | 1.1% | 1.0% |
现金转化率NUTXRAMP
| Q4 25 | 5.95× | — | ||
| Q3 25 | 1.80× | 2.09× | ||
| Q2 25 | — | -2.04× | ||
| Q1 25 | 2.40× | — | ||
| Q4 24 | 0.00× | 4.02× | ||
| Q3 24 | — | 32.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
RAMP
暂无分部数据
